Stem Cells Heal Intestinal Disease in Premature Infants by Colleen Fleiss on May 1, 2021 at 1:16 AM
A human placental-derived stem cell (hPSC) therapy strategy is found to treat necrotizing enterocolitis (intestinal bowel disease) that affects up to 10 percent of premature infants.
The intestinal bowel disease is at a very vulnerable and developmentally crucial time can lead to serious infection and death.
The cause of necrotizing enterocolitis is unclear - it is a multi-faceted disease that results from the complex interaction of early bacterial colonization, an exaggerated inflammatory response, and immature intestinal tissue.
‘Necrotizing enterocolitis is a life-threatening intestinal disease that is a leading cause of mortality in premature infants and treatment options remain elusive.’
Mutasi Baru Virus Covid Turunkan Efikasi, Pasien Sembuh Bisa Terinfeksi Lagi
tribunnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribunnews.com Daily Mail and Mail on Sunday newspapers.
Mutasi Virus Covid-19 E484K Terdeteksi di Indonesia, 1 Kasus Ditemukan di Jakarta
tribunnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribunnews.com Daily Mail and Mail on Sunday newspapers.